We are live on
!
Find out more
DMKJ
David M. Knott Jr Portfolio holdings
AUM
$168M
1-Year Est. Return
60.36%
This Fund
S&P 500
This Quarter
Est. Return
+21.23%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$248M
AUM Growth
+$27.4M
(+12%)
Cap. Flow
-$3.33M
Cap. Flow
% of AUM
-1.34%
Top 10 Holdings %
Top 10 Hldgs %
69.93%
Holding
98
New
13
Increased
15
Reduced
10
Closed
10
Top Buys
| 1 |
Rezolute
RZLT
|
+$1.83M |
| 2 |
Praxis Precision Medicines
PRAX
|
+$1.36M |
| 3 |
Cytokinetics
CYTK
|
+$1.24M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$985K |
| 5 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$666K |
Top Sells
| 1 |
Calumet Specialty Products
CLMT
|
+$7.4M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
+$2.91M |
| 3 |
INZY
Inozyme Pharma
INZY
|
+$2.66M |
| 4 |
ESGR
Enstar Group
ESGR
|
+$2.52M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$2.5M |
Sector Composition
| 1 | Healthcare | 34.94% |
| 2 | Materials | 21.4% |
| 3 | Financials | 15.49% |
| 4 | Communication Services | 11.05% |
| 5 | Industrials | 1.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Calumet Specialty Products
CLMT
$3.58B
| $51.6M | 20.79% |
2,825,231
-450,000
| -14% | -$7.4M |
|
2
Apollo Global Management
APO
$71.1B
| $30M | 12.09% |
225,000
| – | – |
|
3
Alphabet (Google) Class C
GOOG
$4.32T
| $27.3M | 11.02% |
112,220
| – | – |
|
|
4
Janus Henderson AAA CLO ETF
JAAA
$29B
| $22.2M | 8.96% |
437,754
-57,500
| -12% | -$2.91M |
|
5
CALL
Darling Ingredients
DAR
$9.72B
| $9.26M | 3.73% |
+300,000
| New | +$10M |
|
6
Xeris Biopharma Holdings
XERS
$1.5B
| $8.26M | 3.33% |
1,015,000
-45,000
| -4% | -$299K |
|
|
7
Syndax Pharmaceuticals
SNDX
$2.01B
| $6.58M | 2.66% |
428,000
+75,222
| +21% | +$985K |
|
8
JPMorgan Chase
JPM
$912B
| $6.43M | 2.59% |
20,374
-611
| -3% | -$182K |
|
9
Travere Therapeutics
TVTX
$5.14B
| $6.21M | 2.51% |
260,000
| – | – |
|
|
AVDL
10
DELISTED
Avadel Pharmaceuticals
AVDL
| $5.54M | 2.24% |
363,000
-63,000
| -15% | -$820K |
|
11
Protagonist Therapeutics
PTGX
$8.49B
| $5.51M | 2.22% |
83,000
+3,000
| +4% | +$171K |
|
12
BridgeBio Pharma
BBIO
$15.7B
| $4.41M | 1.78% |
85,000
+5,000
| +6% | +$244K |
|
13
DocGo
DCGO
$63M
| $4.18M | 1.68% |
3,070,850
| – | – |
|
|
VRNA
14
DELISTED
Verona Pharma
VRNA
| $4.09M | 1.65% |
38,355
-16,645
| -30% | -$1.74M |
|
|
LENZ
15
LENZ Therapeutics
LENZ
$153M
| $3.82M | 1.54% |
82,000
| – | – |
|
16
Catalyst Pharmaceutical
CPRX
| $3.72M | 1.5% |
189,000
+13,000
| +7% | +$267K |
|
|
17
Rezolute
RZLT
$421M
| $2.58M | 1.04% |
+275,000
| New | +$1.83M |
|
18
Viridian Therapeutics
VRDN
$1.99B
| $2.52M | 1.01% |
116,574
+25,091
| +27% | +$453K |
|
19
CSX Corp
CSX
$94.6B
| $2.48M | 1% |
70,000
| – | – |
|
20
Liquidia Corp
LQDA
$6.69B
| $2.45M | 0.99% |
107,783
+17,783
| +20% | +$386K |
|
|
ACLX
21
DELISTED
Arcellx
ACLX
| $2.11M | 0.85% |
25,700
| – | – |
|
22
Pfizer
PFE
$143B
| $1.9M | 0.77% |
74,537
| – | – |
|
23
AllianceBernstein
AB
$3.58B
| $1.83M | 0.74% |
48,000
| – | – |
|
24
AtriCure
ATRC
$1.8B
| $1.69M | 0.68% |
48,000
+1,557
| +3% | +$53.6K |
|
|
25
Cytokinetics
CYTK
$10.9B
| $1.65M | 0.66% |
+30,000
| New | +$1.24M |
|
Similar funds
DI
WFS
CCG
7CM
TT
MAG
PFA
CW